Shandong Bailong Chuangyuan Bio-Tech Future Growth
Future criteria checks 5/6
Shandong Bailong Chuangyuan Bio-Tech is forecast to grow earnings and revenue by 34.2% and 30.5% per annum respectively. EPS is expected to grow by 34.1% per annum. Return on equity is forecast to be 18.3% in 3 years.
Key information
34.2%
Earnings growth rate
34.1%
EPS growth rate
Food earnings growth | 38.5% |
Revenue growth rate | 30.5% |
Future return on equity | 18.3% |
Analyst coverage | Low |
Last updated | 28 Feb 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 1,666 | 408 | 304 | N/A | 3 |
12/31/2024 | 1,386 | 341 | 120 | N/A | 3 |
12/31/2023 | 868 | 193 | N/A | N/A | N/A |
9/30/2023 | 825 | 174 | -70 | 187 | N/A |
6/30/2023 | 742 | 163 | -29 | 191 | N/A |
3/31/2023 | 719 | 155 | -9 | 167 | N/A |
12/31/2022 | 722 | 151 | -26 | 150 | N/A |
9/30/2022 | 732 | 147 | -40 | 141 | N/A |
6/30/2022 | 739 | 131 | -13 | 143 | N/A |
3/31/2022 | 717 | 128 | -10 | 95 | N/A |
12/31/2021 | 653 | 104 | 40 | 96 | N/A |
9/30/2021 | 605 | 99 | -15 | 51 | N/A |
6/30/2021 | 566 | 97 | -33 | 32 | N/A |
3/31/2021 | 540 | 98 | 46 | 119 | N/A |
12/31/2020 | 500 | 96 | 37 | 122 | N/A |
9/30/2020 | 479 | 93 | 83 | 150 | N/A |
6/30/2020 | 464 | 92 | 75 | 138 | N/A |
3/31/2020 | 416 | 77 | -1 | 58 | N/A |
12/31/2019 | 421 | 83 | 8 | 64 | N/A |
12/31/2018 | 356 | 65 | 1 | 89 | N/A |
12/31/2017 | 311 | 64 | 77 | 113 | N/A |
12/31/2016 | 336 | 65 | N/A | 60 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 605016's forecast earnings growth (34.2% per year) is above the savings rate (2.9%).
Earnings vs Market: 605016's earnings (34.2% per year) are forecast to grow faster than the CN market (23.8% per year).
High Growth Earnings: 605016's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 605016's revenue (30.5% per year) is forecast to grow faster than the CN market (14.4% per year).
High Growth Revenue: 605016's revenue (30.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 605016's Return on Equity is forecast to be low in 3 years time (18.3%).